5 stories found
Biotechnology firm ImageneBio announced its participation in the H.C. Wainwright 28th Annual Global Investment Conference in New York, aiming to engage with investors regarding its pipeline and strategic developments.
ImageneBio's stock saw a significant increase after the company announced it had secured $30 million in new financing.
ImageneBio, Neurogene, and Compugen have announced their participation in the H.C. Wainwright 28th Annual Global Investment Conference. The event will provide these biotechnology companies with a platform to present their strategies to institutional investors.
ImageneBio, Inc. has announced its GAAP EPS for the latest quarter, reporting a loss of $9.64 per share.
Parkit Enterprise, Healwell AI, ImageneBio, and Hyperliquid Strategies have all reported their financial results for the first quarter.